On May 10, 2024, the United States Patent and Trademark Office (“USPTO”) published a notice of proposed rulemaking in the Federal Register that could dramatically impact prosecution practices, especially for those...more
5/20/2024
/ Double Patent ,
Life Sciences ,
Obviousness ,
Patent Applicants ,
Patent Applications ,
Patent Litigation ,
Patents ,
Proposed Rules ,
Public Comment ,
Terminal Disclaimer ,
USPTO
When the U.S. Food and Drug Administration approves a new drug, it also approves a package insert of the drug, known as a “product label.” A pharmaceutical company marketing a generic product is required to package their...more